These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 21088277)
1. Effect of nitroxoline on angiogenesis and growth of human bladder cancer. Shim JS; Matsui Y; Bhat S; Nacev BA; Xu J; Bhang HE; Dhara S; Han KC; Chong CR; Pomper MG; So A; Liu JO J Natl Cancer Inst; 2010 Dec; 102(24):1855-73. PubMed ID: 21088277 [TBL] [Abstract][Full Text] [Related]
3. The Role of Methionine Aminopeptidase 2 in Lymphangiogenesis. Esa R; Steinberg E; Dror D; Schwob O; Khajavi M; Maoz M; Kinarty Y; Inbal A; Zick A; Benny O Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708166 [TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of amino-terminal methionine processing by TNP-470 and ovalicin in endothelial cells. Turk BE; Griffith EC; Wolf S; Biemann K; Chang YH; Liu JO Chem Biol; 1999 Nov; 6(11):823-33. PubMed ID: 10574784 [TBL] [Abstract][Full Text] [Related]
5. Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589. Qian DZ; Kato Y; Shabbeer S; Wei Y; Verheul HM; Salumbides B; Sanni T; Atadja P; Pili R Clin Cancer Res; 2006 Jan; 12(2):634-42. PubMed ID: 16428510 [TBL] [Abstract][Full Text] [Related]
6. Novel inhibitors targeted to methionine aminopeptidase 2 (MetAP2) strongly inhibit the growth of cancers in xenografted nude model. Chun E; Han CK; Yoon JH; Sim TB; Kim YK; Lee KY Int J Cancer; 2005 Mar; 114(1):124-30. PubMed ID: 15523682 [TBL] [Abstract][Full Text] [Related]
7. Role of human cripto-1 in tumor angiogenesis. Bianco C; Strizzi L; Ebert A; Chang C; Rehman A; Normanno N; Guedez L; Salloum R; Ginsburg E; Sun Y; Khan N; Hirota M; Wallace-Jones B; Wechselberger C; Vonderhaar BK; Tosato G; Stetler-Stevenson WG; Sanicola M; Salomon DS J Natl Cancer Inst; 2005 Jan; 97(2):132-41. PubMed ID: 15657343 [TBL] [Abstract][Full Text] [Related]
8. Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin. Griffith EC; Su Z; Turk BE; Chen S; Chang YH; Wu Z; Biemann K; Liu JO Chem Biol; 1997 Jun; 4(6):461-71. PubMed ID: 9224570 [TBL] [Abstract][Full Text] [Related]
9. Characterization of TNP-470-induced modifications to cell functions in HUVEC and cancer cells. Farinelle S; Malonne H; Chaboteaux C; Decaestecker C; Dedecker R; Gras T; Darro F; Fontaine J; Atassi G; Kiss R J Pharmacol Toxicol Methods; 2000; 43(1):15-24. PubMed ID: 11091126 [TBL] [Abstract][Full Text] [Related]
10. Fumarranol, a rearranged fumagillin analogue that inhibits angiogenesis in vivo. Lu J; Chong CR; Hu X; Liu JO J Med Chem; 2006 Sep; 49(19):5645-8. PubMed ID: 16970390 [TBL] [Abstract][Full Text] [Related]
11. SKLB610: a novel potential inhibitor of vascular endothelial growth factor receptor tyrosine kinases inhibits angiogenesis and tumor growth in vivo. Cao ZX; Zheng RL; Lin HJ; Luo SD; Zhou Y; Xu YZ; Zeng XX; Wang Z; Zhou LN; Mao YQ; Yang L; Wei YQ; Yu LT; Yang SY; Zhao YL Cell Physiol Biochem; 2011; 27(5):565-74. PubMed ID: 21691074 [TBL] [Abstract][Full Text] [Related]
13. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models. Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925 [TBL] [Abstract][Full Text] [Related]
14. Synergistic inhibition of tumor growth and metastasis by combined treatment with TNP-470 and gemcitabine in a human bladder cancer KoTCC-1 model. Muramaki M; Miyake H; Hara I; Kawabata G; Kamidono S J Urol; 2004 Oct; 172(4 Pt 1):1485-9. PubMed ID: 15371876 [TBL] [Abstract][Full Text] [Related]
15. The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis. Naumova E; Ubezio P; Garofalo A; Borsotti P; Cassis L; Riccardi E; Scanziani E; Eccles SA; Bani MR; Giavazzi R Clin Cancer Res; 2006 Mar; 12(6):1839-49. PubMed ID: 16551869 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of endothelial cell function in vitro and angiogenesis in vivo by docetaxel (Taxotere): association with impaired repositioning of the microtubule organizing center. Hotchkiss KA; Ashton AW; Mahmood R; Russell RG; Sparano JA; Schwartz EL Mol Cancer Ther; 2002 Nov; 1(13):1191-200. PubMed ID: 12479700 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological Characterization of SDX-7320/Evexomostat: A Novel Methionine Aminopeptidase Type 2 Inhibitor with Anti-tumor and Anti-metastatic Activity. Cornelius P; Mayes BA; Petersen JS; Turnquist DJ; Dufour PJ; Dannenberg AJ; Shanahan JM; Carver BJ Mol Cancer Ther; 2024 May; 23(5):595-605. PubMed ID: 38530115 [TBL] [Abstract][Full Text] [Related]
18. The chemopreventive agent oltipraz possesses potent antiangiogenic activity in vitro, ex vivo, and in vivo and inhibits tumor xenograft growth. Ruggeri BA; Robinson C; Angeles T; Wilkinson J; Clapper ML Clin Cancer Res; 2002 Jan; 8(1):267-74. PubMed ID: 11801568 [TBL] [Abstract][Full Text] [Related]
19. Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2. Griffith EC; Su Z; Niwayama S; Ramsay CA; Chang YH; Liu JO Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15183-8. PubMed ID: 9860943 [TBL] [Abstract][Full Text] [Related]
20. Suppression of glioblastoma growth and angiogenesis through molecular targeting of methionine aminopeptidase-2. Lin M; Zhang X; Jia B; Guan S J Neurooncol; 2018 Jan; 136(2):243-254. PubMed ID: 29116484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]